rdf:type |
|
lifeskim:mentions |
umls-concept:C0016658,
umls-concept:C0022417,
umls-concept:C0029456,
umls-concept:C0030705,
umls-concept:C0044410,
umls-concept:C0102118,
umls-concept:C0332167,
umls-concept:C0814861,
umls-concept:C1280500,
umls-concept:C1556094,
umls-concept:C1706309
|
pubmed:issue |
6
|
pubmed:dateCreated |
2011-5-17
|
pubmed:abstractText |
The authors conducted a randomized controlled trial to clarify the efficacy and safety of alendronate plus alfacalcidol versus alendronate alone in a clinical setting.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1473-4877
|
pubmed:author |
pubmed-author:A-TOP (Adequate Treatment of Osteoporosis) research group,
pubmed-author:FukunagaMasaoM,
pubmed-author:HosoiTakayukiT,
pubmed-author:KurodaTatsuhikoT,
pubmed-author:MiyakawaNobuakiN,
pubmed-author:NakamuraToshitakaT,
pubmed-author:OhashiYasuoY,
pubmed-author:OhtaHiroakiH,
pubmed-author:OrimoHajimeH,
pubmed-author:ShirakiMasatakaM,
pubmed-author:UemuraYukariY
|
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1273-84
|
pubmed:meshHeading |
|
pubmed:year |
2011
|
pubmed:articleTitle |
Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.
|
pubmed:affiliation |
Health Science University, Yamanashi, Japan.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|